Translating deep learning innovations into clinical medical imaging practice

Deep learning (DL) has fundamentally transformed medical imaging, enabling unprecedented advancements in image quality, automated detection, and diagnostic precision. Despite these technical achievements, a significant translational gap persists between algorithmic development and robust clinical deployment. Unlike prior reviews that focus primarily on algorithmic architectures or single modalities, this structured narrative review provides a comprehensive translational roadmap bridging technical methodologies with clinical applications and market dynamics. We synthesize recent findings across multiple imaging modalities, including X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), and digital pathology, and uniquely integrate seven application domains, including image classification, segmentation, object tracking, augmented imaging, disease prediction, computer-aided diagnosis (CAD), and radiomics, and examine the emerging role of foundation models and vision-language models that are reshaping the paradigm from task-specific to generalizable medical AI. To evaluate market translation, we analyze the expansive landscape of over 1300 FDA-cleared AI/machine learning (ML)-enabled medical devices and compare evolving international frameworks governing clinical deployment, specifically the FDA, EMA, and the EU AI Act. Our analysis reveals that while DL achieves specialist-level performance, cleared devices predominantly focus on radiology triage rather than autonomous diagnosis, and widespread adoption remains hindered by data quality challenges, limited model interpretability, and complex regulatory requirements. Realizing DL’s transformative potential requires interdisciplinary collaboration focused on standardized evaluation frameworks, diverse multi-institutional datasets, adaptive regulatory pathways for continuously learning algorithms, and ethical safeguards for privacy and equity. This structured narrative review serves as a practical guide for clinicians and engineers navigating the translation from algorithmic innovation to safe, equitable clinical adoption.